| The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62 JF Linares, T Cid-Diaz, A Duran, M Osrodek, A Martinez-Ordoñez, ... Cell reports 39 (6), 2022 | 38 | 2022 |
| Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid‐induced muscle cell atrophy T Cid‐Díaz, I Santos‐Zas, J González‐Sánchez, U Gurriarán‐Rodríguez, ... Journal of cachexia, sarcopenia and muscle 8 (6), 974-990, 2017 | 35 | 2017 |
| β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells I Santos-Zas, U Gurriarán-Rodríguez, T Cid-Díaz, G Figueroa, ... Cellular and molecular life sciences 73, 617-635, 2016 | 33 | 2016 |
| Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer A Martinez-Ordoñez, A Duran, M Ruiz-Martinez, T Cid-Diaz, X Zhang, ... Cancer Cell 41 (2), 252-271. e9, 2023 | 31 | 2023 |
| Mouse model of colorectal cancer: orthotopic co-implantation of tumor and stroma cells in cecum and rectum H Kasashima, A Duran, T Cid-Diaz, Y Muta, H Kinoshita, E Batlle, ... STAR protocols 2 (1), 100297, 2021 | 19 | 2021 |
| Obestatin controls skeletal muscle fiber-type determination I Santos-Zas, T Cid-Díaz, J González-Sánchez, U Gurriarán-Rodriguez, ... Scientific Reports 7 (1), 2137, 2017 | 18 | 2017 |
| Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis T Cid‐Díaz, S Leal‐López, F Fernández‐Barreiro, J González‐Sánchez, ... Journal of cachexia, sarcopenia and muscle 12 (2), 493-505, 2021 | 17 | 2021 |
| An orthotopic implantation mouse model of hepatocellular carcinoma with underlying liver steatosis H Kasashima, A Duran, T Cid-Diaz, Y Kudo, MT Diaz-Meco, J Moscat STAR protocols 1 (3), 100185, 2020 | 15 | 2020 |
| Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment J González‐Sánchez, A Sánchez‐Temprano, T Cid‐Díaz, ... Journal of cachexia, sarcopenia and muscle 9 (6), 1063-1078, 2018 | 11 | 2018 |
| Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis Y Muta, JF Linares, A Martinez-Ordoñez, A Duran, T Cid-Diaz, H Kinoshita, ... Nature communications 14 (1), 8075, 2023 | 8 | 2023 |
| Whole-mount staining of mouse colorectal cancer organoids and fibroblast-organoid co-cultures A Martinez-Ordoñez, T Cid-Diaz, A Duran, Q Han, J Moscat, ... STAR protocols 4 (2), 102243, 2023 | 3 | 2023 |
| Epithelial aPKC deficiency leads to stem cell loss preceding metaplasia in colorectal cancer initiation H Kinoshita, A Martinez-Ordoñez, T Cid-Diaz, Q Han, A Duran, Y Muta, ... Developmental Cell, 2024 | 2 | 2024 |
| Air-liquid organotypic assays to investigate cellular crosstalk in the tumor microenvironment of cancer cells T Cid-Diaz, AC Lodeiro, A Duran, J Moscat, MT Diaz-Meco STAR protocols 3 (3), 101635, 2022 | 1 | 2022 |
| Publisher Correction: Obestatin controls skeletal muscle fiber-type determination I Santos-Zas, T Cid-Díaz, J González-Sánchez, U Gurriarán-Rodriguez, ... Scientific Reports 8, 2018 | 1 | 2018 |
| The obestatin/GPR39 system: a potential target in the treatment of pancreatic cancer A Calviño-Lodeiro, S Costas-Abalde, I Santos-Zas, S Leal-López, ... Pancreatology 24, e23, 2024 | | 2024 |
| Obestatin delineates apoptosis via a caspase-dependent modulation of p21 in human PDAC cells A Calviño-Lodeiro, S Costas-Abalde, I Santos-Zas, S Leal-López, ... Pancreatology 24, e62, 2024 | | 2024 |
| Regulation of pancreatic cancer-associated muscle wasting through the obestatin/GPR39 system: a pilot study A Calviño-Lodeiro, S Costas-Abalde, I Santos-Zas, S Leal-López, ... Pancreatology 24, e107, 2024 | | 2024 |
| Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma S Nishimura, JF Linares, A L’Hermitte, A Duran, T Cid-Diaz, ... Molecular cell 84 (23), 4660-4676. e10, 2024 | | 2024 |
| Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer SS Chatterjee, JF Linares, T Cid-Diaz, A Duran, MIK Khan, M Osrodek, ... Nature Communications 15 (1), 9755, 2024 | | 2024 |
| Protocol to characterize mouse intestinal epithelial cell lineage using Opal multiplex immunofluorescence A Martinez-Ordoñez, H Kinoshita, T Cid-Diaz, A Duran, M Osrodek, ... STAR protocols 5 (3), 103303, 2024 | | 2024 |
